Riskpilot← Back to searchSign inGet full accessNorrbehandling AB
ABActiveOrg 5590994157Tegskiftesvägen 7Other residential care activities n.e.c. · NACE 8799Est. 20175-9 employees
Revenue 2025
SEK 10,3M
+13% vs 2024
EBITDA margin
2.2%
-85% vs 2024
Equity ratio
43.1%
Financial strength
Net profit 2025
SEK -105K
-118% vs 2024
| Revenue | SEK 10,3M | +13% |
| EBITDA | SEK 229K | -85% |
| Net profit | SEK -105K | -118% |
| Total assets | SEK 5,7M | -7% |
| Equity | SEK 2,5M | -16% |
| Employees | — | — |
Legal name
Norrbehandling AB
Org number
5590994157
Legal form
Aktiebolag
NACE code
8799 · Other residential care activities n.e.c.
Founded
2 februari 2017
Share capital
SEK 200 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Gustafsson, Carl Hjalmar Marcus
Company purpose
Bolaget skall bedriva vård och omsorg med boende samt därmed förenlig verksamhet.
Address
Tegskiftesvägen 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 560 | 9 632 | 9 076 | 9 093 | 10 314 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 193 | 2 031 | −76 | 1 478 | 229 |
| Depreciation & amort. | −62 | −204 | −224 | −265 | −275 |
| EBIT | 1 131 | 1 827 | −300 | 1 213 | −46 |
| Net financials | −19 | −32 | −53 | −67 | −60 |
| Profit before tax | 851 | 1 317 | −171 | 776 | −105 |
| Tax | −192 | −279 | 22 | −181 | −0 |
| Net profit | 659 | 1 038 | −149 | 595 | −105 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 068 | 5 556 | 5 000 | 6 173 | 5 745 |
| Equity | 1 612 | 2 496 | 2 347 | 2 941 | 2 476 |
| Long-term debt | 100 | 961 | 482 | 495 | 329 |
| Short-term debt | 865 | 1 129 | 1 382 | 1 577 | 1 781 |
| Total debt | 965 | 2 090 | 1 864 | 2 072 | 2 110 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20212025
Equity ratio
43.1%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
-4.2%
This company
18.4%
Market median
-123% vs market
20212025
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20212025
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20212025
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RP Chief Auditor | Chief Auditor | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Chairman | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Norrbehandling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Per-Olof Larsson | Chief Auditor | 0 companies |
| Berit Mariann Gustafsson | Deputy Board Member | 0 companies |
| J R Eric Lindgren Gustafsson | Board of Directors | 0 companies |
| Emmeli K A Lindgren Gustafsson | Deputy Board Member | 0 companies |
| Carl Hjalmar Marcus Gustafsson | Chairman | 0 companies |